Efficacy Study of COmbination of Edoxaban and Physiotherapy on PRevention and Thrombogenicity of Venous-Thromboembolism in patients after Total Knee Arthroplasty

Trial Profile

Efficacy Study of COmbination of Edoxaban and Physiotherapy on PRevention and Thrombogenicity of Venous-Thromboembolism in patients after Total Knee Arthroplasty

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2017

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms ESCORT-TKA
  • Most Recent Events

    • 16 Sep 2017 Primary endpoint has been met. (Differences in incidence rate of venous thromboembolism 7 days after opetration,and the changes in T-TAS parameters between edoxaban plus physiotherapy group and physiotherapy only group.) as per result published in the Circulation Journal
    • 16 Sep 2017 Results published in the Circulation Journal
    • 22 Jul 2017 Status changed from suspended to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top